What's New
FTD in the News
“Vogue” Covers AFTD’s 2022 Hope Rising Benefit
(L-R: AFTD CEO Susan L-J Dickinson, AFTD Board member Donald E. Newhouse, Hope Rising Benefit Chair David…
“Die Hard” Actor Bruce Willis Steps Away from Career Following Aphasia Diagnosis
Bruce Willis is stepping away from his acting career after experiencing health issues related to an aphasia…
Novelist Julie Otsuka Shares Mother’s Journey with FTD on “Fresh Air” Podcast
Best-selling novelist Julie Otsuka discussed how her mother’s FTD diagnosis inspired the main character of her new…
UCL, NIH Study Determines Why Genetic Variant Associated with FTD Worsens Disease Outcome
A recent study led by researchers at the University College London (UCL) and the National Institutes of…
Wisconsin Couple Impacted by FTD Share Their Love Story in Local Newspaper
Wisconsin couple Joe and Barb Spiegelhoff were featured in a Lake Geneva Regional News article, sharing how…
“Sports Illustrated” 2022 Swim Search Finalist Raises FTD Awareness in Honor of Mother
Model Nicole Petrie is raising national FTD awareness and using her modeling career to be “a voice…
FNIH Announces Neurofilament Project Designed to Improve Diagnostic Process for Familial FTD
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, in partnership with AFTD, recently launched…
AFTD Ambassador Advocates for Dementia Care Management Legislation in “News & Observer” Editorial
AFTD Ambassador Dr. Gerald Lazarus wrote a guest editorial for the North Carolina-based newspaper The News &…
Rare Disease Day 2022: Think FTD
February 28 marks Rare Disease Day, an annual campaign intended to increase awareness of rare diseases and their…
Arkuda Therapeutics Secures Funding for FTD-GRN Research
Biotechnology company Arkuda Therapeutics recently acquired multi-million dollar funding to continue its research program targeted at increasing…
English 
Spanish